• Dec 09, 2024

Why Cryptocurrencies XRP, Dogecoin, and Shiba Inu Are Struggling Today

Cryptocurrencies took a breather today as the price of Bitcoin retreated from $100,000 and traded around $97,500 as of 1 p.m. ET. Treasury yields rose in anticipation of new inflation data later this week, but otherwise, it was not immediately clear what drove the sell-off. Other cryptocurrencies followed Bitcoin's lead and struggled today as well.

  • Dec 09, 2024

Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock

Jefferies has upgraded Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), citing the company’s robust cystic fibrosis base business and the additional upside from the new LNP/ mRNA therapy (around $1 billion opportunity) and “triple pill” regimens. The company’s pipeline can potentially exceed expectations if the data is positive. The analyst views the risk/reward balance as mostly neutral for 2024. The pain program stands out as a potential blockbuster, especially with the upcoming launch for acute pai

  • Dec 09, 2024

Broadcom Likely For Upside Backed By AI Pipeline, Market Recovery, VMWare Synergy: Analyst

JP Morgan analyst Harlan Sur maintained an Overweight rating on Broadcom Inc (NASDAQ:AVGO) with a price target of $210. Broadcom will report fiscal fourth-quarter 2024 earnings on Thursday. Sur noted a strong demand profile for AI products, continued cyclical recovery in its diversified semiconductor (ex-AI) end markets, and unlocked VMWare revenue synergy. As a result, the analyst expects revenue, earnings, and free cash flow to be better than JP Morgan and consensus expectations (revenues comi

  • Dec 09, 2024

MicroStrategy Buys Another $2.1 Billion Worth of Bitcoin

The company spent roughly $2.1 billion to add 21,550 bitcoins to its stash that has now grown to 423,650 BTC, and is worth close to $41.5 billion at current prices. MicroStrategy now controls over 2% of the 21 million bitcoin that will ever exist.